SCHEMBL20448367

SCHEMBL20448367

[c]1ccc(Nc2cn[nH]c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 1/20 0.39
PIM1 P11309 1/20 0.35
PIM3 Q86V86 1/20 0.35
PIM2 Q9P1W9 1/20 0.35
JAK2 O60674 3/20 0.35
JAK1 P23458 3/20 0.35
JAK3 P52333 2/20 0.35
IKBKE Q14164 2/20 0.34
TBK1 Q9UHD2 2/20 0.34
TYK2 P29597 2/20 0.33
PDE4B Q07343 3/20 0.33
LRRK2 Q5S007 1/20 0.33
ALK Q9UM73 1/20 0.33
AKT1 P31749 1/20 0.32
AKT2 P31751 1/20 0.32
KCNH2 Q12809 1/20 0.32
PIK3CD O00329 1/20 0.32
PIK3CA P42336 1/20 0.32
PIK3CB P42338 1/20 0.32
MTOR P42345 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12467721 0.75 HSD17B10 (0.44)
SCHEMBL28201678 0.72 ADRA2A (0.45) MAP4K4KDM1A
SCHEMBL197153 0.68 AKT2 (0.61) PIM1PIM3PIM2AKT1AKT2
SCHEMBL147419 0.67 RAD52 (0.54) PIM1KCNH2LMNA
SCHEMBL69437 0.66 HSD17B10 (0.67) LMNA
SCHEMBL13725360 0.66 AURKA (0.52) PIM1PDE4B
SCHEMBL12479651 0.65 MAP4K4 (0.40) MAP4K4PIM1PIM3PIM2JAK2
SCHEMBL4561597 0.65 JAK2 (0.44) MAP4K4PIM1PIM3PIM2JAK2
SCHEMBL13726289 0.65 EIF2AK2 (0.56)
SCHEMBL30076634 0.64 GRM4 (0.52) MAP4K4KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180265467-A1 PYRAZOLIDINE DERIVATIVES AND RELATED COMPOUNDS SELVITA S.A. (PL) 2018-09-20 US claimed
EP-3356331-A1 PYRAZOLIDINE DERIVATIVES AND RELATED COMPOUNDS Selvita S.A. (PL) 2018-08-08 EP claimed
US-20180265467-A1 PYRAZOLIDINE DERIVATIVES AND RELATED COMPOUNDS SELVITA S.A. (PL) 2018-09-20 US disclosed
EP-3356331-A1 PYRAZOLIDINE DERIVATIVES AND RELATED COMPOUNDS Selvita S.A. (PL) 2018-08-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180265467-A1 PYRAZOLIDINE DERIVATIVES AND RELATED COMPOUNDS LDHB, LDHA, PDK1 MAP4K4 1533/4885PIM1 665/4885PIM3 857/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.